Milestone Scientific (NYSE:MLSS) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Thursday morning. The firm issued a hold rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Price Performance

MLSS stock opened at $0.81 on Thursday. The firm has a market cap of $63.09 million, a price-to-earnings ratio of -11.57 and a beta of 1.10. The firm has a fifty day moving average price of $0.81 and a two-hundred day moving average price of $0.86. Milestone Scientific has a 1-year low of $0.52 and a 1-year high of $1.10.

Insiders Place Their Bets

In other news, Director Leonard Osser sold 107,984 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the sale, the director now owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Over the last ninety days, insiders have sold 109,193 shares of company stock valued at $101,634. 24.75% of the stock is currently owned by insiders.

Institutional Trading of Milestone Scientific

Several institutional investors have recently added to or reduced their stakes in the stock. Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific during the 3rd quarter worth $48,000. World Investment Advisors LLC purchased a new stake in shares of Milestone Scientific in the 3rd quarter valued at $91,000. Finally, Geode Capital Management LLC increased its stake in Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the period. 5.79% of the stock is currently owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.